CLINICAL_TRIALS
trial_result
· 2020-03-25
Clinical Trial Update: Study of Ataluren (PTC124) in Cystic Fibrosis [Phase 3]
Summary
Phase 3 study of ataluren (PTC124) in cystic fibrosis was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PTC Therapeutics | Conditions: Cystic Fibrosis | Phase 3 | Status: TERMINATED | Results posted: 2020-03-25